Oyster Point Pharma (OYST)
NASDAQ:OYST
US Market
Holding OYST?
Track your performance easily

Oyster Point Pharma (OYST) Income Statement

0 Followers

Oyster Point Pharma Income Statement

Last quarter (Q ), Oyster Point Pharma's total revenue was $5.59M, a decrease of -68.84% from the same quarter last year. In Q, Oyster Point Pharma's net income was $-36.75M. See Oyster Point Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
TTM
Dec 21Dec 20Dec 19Dec 18Dec 17
Total Revenue
$ 19.58M$ 24.54M$ 0.00$ 0.00$ 0.00$ 0.00
Cost of Revenue
$ 4.52M$ 1.52M$ 0.00---
Gross Profit
$ 15.06M$ 23.01M$ 0.00---
Operating Expense
$ 173.52M$ 119.67M$ 70.99M$ 47.30M$ 16.74M$ 5.68M
Operating Income
$ -158.45M$ -96.66M$ -70.99M$ -47.30M$ -16.74M$ -5.68M
Net Non Operating Interest Income Expense
$ -12.33M$ -3.73M$ 0.00$ 1.59M$ 233.00K$ -444.00K
Other Income Expense
$ -5.87M$ -270.00K$ 469.00K$ 1.59M-$ -474.00K
Pretax Income
$ -176.65M$ -100.66M$ -70.52M$ -45.71M$ -16.50M$ -6.60M
Tax Provision
------
Earnings From Equity Interest Net Of Tax
------
Net Income Common Stockholders
$ -176.65M$ -100.66M$ -70.52M$ -45.71M$ -16.50M$ -19.14M
Basic EPS
$ -6.65$ -3.87$ -2.92$ -9.97$ -1.20$ -2.12
Diluted EPS
$ -6.65$ -3.87$ -2.92$ -9.97$ -1.20$ -2.12
Basic Average Shares
$ 106.40M$ 26.04M$ 24.13M$ 4.59M$ 13.80M$ 9.02M
Diluted Average Shares
$ 106.40M$ 26.04M$ 24.13M$ 4.59M$ 13.80M$ 9.02M
Dividend Per Share
------
Total Operating Income As Reported
------
Reported Normalized Basic E P S
------
Reported Normalized Diluted E P S
------
Rent Expense Supplemental
------
Total Expenses
$ 178.04M$ 121.19M$ 70.99M$ 47.30M$ 16.74M$ 5.68M
Net Income From Continuing And Discontinued Operation
$ -176.65M$ -100.66M$ -70.52M$ -45.71M$ -16.50M$ -6.60M
Normalized Income
$ -176.65M$ -100.66M$ -70.52M$ -45.71M$ -16.50M$ -6.13M
Interest Expense
$ 12.33M$ 3.73M$ 0.00-$ 0.00$ 488.00K
EBIT
$ -164.32M$ -96.92M$ -70.52M$ -47.30M$ -16.74M$ -6.11M
EBITDA
$ -164.01M$ -96.78M$ -70.44M$ -47.12M$ -16.74M$ -6.11M
Currency in USD

Oyster Point Pharma Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis